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Abstract
Tyrosylprotein sulfotransferase 2 (TPST2) is one of the enzymes responsible for tyrosine O-sulfation and catalyzes the
sulfation of the specific tyrosine residue of thyroid stimulating hormone receptor (TSHR). Since this modification is
indispensable for the activation of TSH signaling, a non-functional TPST2 mutation (Tpst2
grt) in DW/J-grt mice leads to
congenital hypothyroidism (CH) characterized by severe thyroid hypoplasia and dwarfism related to TSH hyporesponsive-
ness. Previous studies indicated that the genetic background of the 129
+Ter/SvJcl (129) mouse strain ameliorates Tpst2
grt-
induced CH. To identify loci responsible for CH resistance in 129 mice, we performed quantitative trait locus (QTL) analysis
using backcross progenies from susceptible DW/J and resistant 129 mice. We used the first principal component calculated
from body weights at 5, 8 and 10 weeks as an indicator of CH, and QTL analysis mapped a major QTL showing a highly
significant linkage to the distal portion of chromosome (Chr) 2; between D2Mit62 and D2Mit304, particularly close to
D2Mit255. In addition, two male-specific QTLs showing statistically suggestive linkage were also detected on Chrs 4 and 18,
respectively. All QTL alleles derived from the 129 strain increased resistance to growth retardation. There was also a positive
correlation between recovery from thyroid hypoplasia and the presence of the 129 allele at D2Mit255 in male progenies.
These results suggested that the major QTL on Chr 2 is involved in thyroid development. Moreover, since DW/J congenic
strain mice carrying both a Tpst2
grt mutation and 129 alleles in the major QTL show resistance to dwarfism and thyroid
hypoplasia, we confirmed the presence of the resistant gene in this region, and that it is involved in thyroid development.
Further genetical analysis should lead to identification of genes for CH tolerance and, from a better understanding of
thyroid organogenesis and function, the subsequent development of new treatments for thyroid disorders.
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Introduction
Congenital hypothyroidism (CH) is one of the most frequent
endocrinological disorders. It is caused by insufficient production
of thyroid hormone by the thyroid gland, and about 1:3000–4000
newborns are affected by CH. If untreated, they suffer from
irreversible growth delay and mental retardation. In most cases
(80–90%), CH is caused by thyroid dysgenesis (TD) characterized
by abnormal thyroid gland development, such as ectopic thyroid
gland, athyreosis and thyroid hypoplasia [1,2]. Both environmen-
tal and genetic factors affect the development of TD [3–5].
Molecular genetic analyses have identified some TD susceptible
genes in humans; thyroid stimulating hormone receptor (TSHR),
thyroid transcription factor 1 (TTF1), TTF2, paired box gene 8
(PAX8), NKX2.5 and HHEX [1,6,7]. Studies of the spontaneous
mutation and targeted-disruption of the above genes in mice have
also provided insights into the molecular mechanisms of thyroid
organogenesis and thereby formed the basis for molecular genetic
studies in human patients affected by TD [1,8]. Numerous studies
have used a candidate gene approach to identify genes involved in
common forms of TD. However, most forms of TD appear
sporadically, and no significant linkage between the TD phenotype
and haplotypes surrounding TSHR, TTF1, TTF2 and PAX8 locus
have been reported [9]. Moreover, the incomplete penetrance and
the variable expression observed in familial cases of hypothyroid-
ism demonstrate that TD-associated CH is a genetically
heterogeneous disease [9,10]. Thus, there is little information
available on the genetic factors involved in thyroid disease.
DW/J-grt is a mouse model for TD-associated CH that is
characterized by autosomal recessive growth retardation, signifi-
cantly lowered T3 and T4 levels, and severe thyroid hypoplasia
related to TSH hyporesponsiveness [11]. Previously, we identified
a point mutation (Tpst2
grt) in the tyrosylprotein sulfotransferase 2
(Tpst2) gene causing a decrease in enzymatic activity [12]. TPST2
is one of the enzymes responsible for tyrosine O-sulfation and
catalyzes the sulfation of tyrosine 385 of TSHR [13]. Since this
modification is indispensable for the activation of TSH signaling
[12–14] and, furthermore, since signal transduction via TSHR is
prerequisite for the development and function of thyroid gland
[15,16], DW/J-grt mice develop CH [12]. Previously, to examine
the effects of genetic background on hypothyroidism, we produced
congenic strains carrying this Tpst2
grt mutation on the genetic
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+Ter/SvJcl
(129), and analyzed growth rate and thyroid function. The B6
congenic mice show a severe hypothyroid phenotype similar to the
DW/J (DW) strain. In contrast, and interestingly, the 129
congenic mice exhibit normal growth and thyroid function. This
result suggests that 129 strain have resistant gene(s) against CH
[17]. In order to identify the resistant gene(s) against Tpst2
grt-
induced CH, we carried out quantitative trait locus (QTL) analysis
using backcross progenies from susceptible DW and resistant 129
mice. Because the tolerance to growth retardation in 129 strain is
caused by the normal thyroid development and function in spite of
TSH hyporesponsiveness [17], body weight is expected to reflect
the severity of CH. We used the first principal component of body
weights at 5, 8 and 10 weeks age, calculated by principal
component analysis, as an indicator of CH. QTL analysis mapped
a major QTL showing a highly significant linkage to the distal
portion of chromosome (Chr) 2; between D2Mit62 and D2Mit304,
particularly close to D2Mit255. In addition, a further two QTLs
showing suggestive statistical linkages were detected on Chrs 4 and
18, respectively, in the male progenies. High percentages of the
variance (63–69%) at D2Mit255 also supported the validity of the
QTL on Chr 2 as a powerful modifier for growth delay by Tpst2
grt.
Statistically significant correlations between body weight and
thyroid index for both sexes demonstrated that the growth
retardation in backcross progeny is related to thyroid hypoplasia.
Also, a significant difference in male thyroid index between
genotypes at D2Mit255 suggested the major tolerant gene on Chr
2 is involved in thyroid development. Finally, we generated DW
congenic strain mice carrying both a Tpst2
grt mutation and 129
alleles in the major QTL, and confirmed the recovery from both
growth retardation and thyroid hypoplasia.
Materials and Methods
Ethical Statement
All research and experimental protocols were approved by the
Regulation for the Care and Use of Laboratory Animals,
Hokkaido University (approval ID: No. 110226), and performed
under the guidance of the Institute for Laboratory Animal
Research (ILAR). All animals were housed in a facility approved
by the American Association for Accreditation of Laboratory
Animal Care (AAALAC) International.
Animals
129 mice were purchased from CLEA Japan (129
+Ter/SvJcl;
Tokyo, Japan). Backcross progenies were obtained by mating DW
female mice heterozygous for Tpst2
grt to DW129-F1 hybrid male
mice heterozygous for Tpst2
grt. Backcross mice homozygous for
Tpst2
grt (BC-Tpst2
grt) were born in accordance with Mendelian
inheritance and the equal sex ratio. Backcross progenies with
homozygotic wild-type alleles for Tpst2 gene (BC-WT) were used
as littermate controls. Genotyping of the Tpst2
grt allele was
performed as previously described [12]. In order to confirm the
effect of the main QTL on Chr 2 between D2Mit62 and D2Mit304
(the 129-derived locus for resistance to CH on Chr 2; Lrch),
congenic strain mice in which the Lrch allele is introduced into the
susceptible DW strain was generated by a marker-assisted speed
congenic strategy [18]. In brief, among the male mice harboring
the 129 alleles between D2Mit62 and D2Mit304, the male mice
with the highest percentage of the DW genetic background,
evaluated using 72 markers (Table S1), were selected for breeding
the next generation. Backcrossing was repeated six times and
finally, congenic mice possessing heterozygous 129 alleles between
D2Mit62 and D2Mit304 (DW.129-[D2Mit62-D2Mit304]; CG)
were produced. Female CG mice heterozygous for both Tpst2
grt
and Lrch alleles were then crossed with DW male mice
heterozygous for Tpst2
grt and their progenies were used for
congenic strain analysis. The animal room was air-conditioned
at 2264uC, maintained at 40–60% relative humidity, and mice
were maintained under a 12 hr light-dark cycle. A standard
laboratory diet, CE-2 (Nihon Clea, Tokyo, Japan), and tap water
were available ad libitum.
Genotyping Analysis
We used 49 (male=26, female=23) BC-Tpst2
grt mice for a
genome-wide scan. Extraction of genomic DNA from tail clips was
performed by a standard method. For QTL analysis, a total of 74–
75 informative microsatellite markers spanning 19 autosomes were
used for the genotyping analysis, as listed in Table S1. The map
positions of the microsatellite markers were based on information
from the Mouse Genome Informatics of Jackson Laboratory
(MGI; http://www.informatics.jax.org/, MGI_4.41). PCR was
carried out with a cycling sequence of 95uC for 5 min (one cycle),
followed by 35 cycles consisting of denaturation at 95uC for
30 sec, primer annealing at 55uC for 30 sec, and extension at
72uC for 30 sec. Amplified samples were electrophoresed with
10% polyacrylamide gels and stained with ethidium bromide. The
stained gels were then visualized and photographed under an
ultraviolet lamp.
QTL Analysis
For the evaluation of resistance to TD-associated CH induced
by Tpst2
grt, we measured body weights at 5, 8 and 10 weeks of age
and conducted principal component analysis. The first principal
component, which provides the comprehensive value of body
weights at each time-point and reflects a synthetic view of growth
retardation, was used as quantitative trait for CH. Principal
component analysis was performed with free software program for
multivariate analysis (mulvar95; http://www.vector.co.jp/soft/
win95/edu/se203904.html). QTL analysis was performed with
the Map Manager QTXb20, software program that uses a
maximum likelihood algorithm with ‘‘interval mapping’’ and
‘‘simultaneous search’’, and permits better localization of loci and
exclusion mapping [19]. Recombination frequencies (%) were
converted into genetic distance (cM) using the Kosambi map
function. This program provides linkage data as a likelihood ratio
statistic (LRS) score. The LRS values were calculated by 10000
random permutations of the trait values relative to genotypes of
the marker loci. Genome-wide significance thresholds were set at
the 37
th (‘‘suggestive’’), 95
th (‘‘significant’’), and 99.9
th (‘‘highly
significant’’) percentiles, which correspond to genome-wide a
values of 0.63, 0.05 and 0.001 times, respectively, based on 10000
random permutation [20]. Since there are significant sex
differences in weekly body weight, the principal component
analysis and QTL analysis were performed separately for each sex.
Histological Analysis of Thyroid Glands
Thyroid glands from 10-week-old mice were fixed with 5%
neutral-buffered formalin and embedded in paraffin. Serial
sections of thyroids were cut at 3 mm and stained with
hematoxylin-eosin. Thyroid indices were calculated as previously
reported [17]. In brief, the thyroid index indicates the average
ratio of total colloid areas per thyroid cross-section area.
Statistics
Statistical analyses were performed using the Stat-View
program (SAS Institute Inc. Cary, USA). T-tests were used to
QTL Analysis for Resistance to Hypothyroidism
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each genotype. The correlation between body weight and thyroid
index was analyzed using Pearson’s correlation test. Scheffe ´’s F
tests were conducted for multiple comparisons between the body
weights of each genotype in the congenic strain analysis. Statistical
significance was set at P,0.05.
Results
Phenotypic Characterization of BC-Tpst2
grt Mice
To verify the effect of genetic background on susceptibility to
growth retardation induced by Tpst2
grt, the body weight of forty-
nine (male=26, female=23) BC-Tpst2
grt mice was measured at 5,
8 and 10 weeks of age. Figure 1 shows the plots of body weights of
BC-Tpst2
grt mice and mice homozygous for Tpst2
grt in DW and 129
congenic strains (DW-Tpst2
grt and 129-Tpst2
grt mice, respectively)
at 8 weeks of age [17]. The body weight of each individual BC-
Tpst2
grt mouse of either sex varied compared to that of DW-Tpst2
grt
or 129-Tpst2
grt mice; i.e., some mice showed severe growth
retardation similar to DW-Tpst2
grt mice whereas, other mice
showed growth comparable to that of resistant 129-Tpst2
grt mice.
This scattered distribution was also observed at 5 and 10 weeks of
age (data not shown). Complete recovery from dwarfism observed
in some backcross progenies of both sexes suggests that the tolerant
gene(s) to growth retardation by CH in the 129 strain follows the
autosomal dominant inheritance pattern. Also, the scattered
distribution of body weight in BC-Tpst2
grt mice suggests that
several genes are involved in the resistance.
Genome-wide Linkage Analysis for Mapping of Tolerant
Genes for CH-related Growth Retardation in Backcross
Mice
To identify the modifier genes for CH, we carried out a
genome-wide linkage analysis using BC-Tpst2
grt mice. The first
principal component calculated from body weights at 5, 8 and 10
weeks of age was used as an indicator for CH. The genome-wide
and detailed linkage maps on Chr 2 are shown in Fig. 2. Although
there were suggestive QTLs on Chrs 4 and 18 in males (detailed
maps are shown in Fig. S1), highly significant linkages were
observed on Chr 2 in both sexes. Table 1 summarizes the
microsatellite markers linked to the trait with highest LRS value
on each Chr, percentage of the variance, genome-wide P value
and phenotypic values of each genotype. All QTL alleles
increased resistance to growth retardation by Tpst2
grt when
contributed by the 129 strain. Since high percentages of the
variance (63–69%) supported the validity of the QTL on Chr 2, as
a powerful modifier for growth delay induced by the Tpst2
grt
mutation, we focused QTL on Chr 2 exclusively. Integrating the
results for both sexes (Fig. 2B), the main modifier locus is
estimated to be between D2Mit62 and D2Mit304, and particularly
close to D2Mit255.
Histological Evaluation of the Thyroid Glands of BC-
Tpst2
grt Mice
Since the tolerance to growth retardation in 129-Tpst2
grt mice is
due to their normal thyroid development and function in spite of
hyporeactivity to TSH signaling [17], we conducted a histological
analysis of the thyroid glands. Thyroid sections of randomly
selected 10-week-old BC-Tpst2
grt mice showed some correlation
between the severity of growth retardation and the degree of
thyroid hypoplasia (Fig. 3A). Namely, the thyroid glands of BC-
Tpst2
grt mice with severe growth delay show more severe
hypoplastic symptoms, such as a decrease in the number of
colloid-filled follicles, diversity in follicle size and increased
replacement of parenchyma cells with adipocytes, compared to
those with milder growth retardation. Next, we carried out a
quantitative evaluation of the severity of thyroid dysplasia using a
‘‘thyroid index’’ (average ratio of total colloid areas per thyroid
cross-section area) as previously described [17]. There was no
correlation between body weight and thyroid index in either sexes
BC-WT (Fig. S2: P=0.1495, r=0.394 and n=15 in males;
P=0.9687, r=20.015, n=10 in females), although there were
significant correlations between them in BC-Tpst2
grt mice of both
sexes (Fig. 3B: P=0.0042, r=0.698 and n=14 in males;
P=0.0441, r=0.586 and n=12 in females). This result demon-
strates that the growth retardation in BC-Tpst2
grt mice is correlated
to the severity of thyroid hypoplasia. In addition, although there
was no significant difference in females, male BC-Tpst2
grt mice
heterozygous for D2Mit255 showed a significant increase in
thyroid index compared to male BC-Tpst2
grt mice homozygous for
D2Mit255 (Fig. 3C). There was no significant difference when
male BC-Tpst2
grt mice were grouped according to genotype at the
weaker QTLs on Chrs 4 and 18, respectively (data not shown).
These results suggest that the main CH resistant gene(s) is located
on Chr 2 near D2Mit255, and that it is involved in thyroid
development.
Evaluation of the Effects of Lrch by Analysis of Congenic
Mice
In order to validate the effects of the 129-derived resistant locus
(locus for resistance to CH: designated Lrch), a DW congenic
mouse strain carrying 129 alleles at this locus was generated
(Fig. 4A). Figure 4B shows the growth curves of each genotype of
CG mice. CG mice with wild-type Tpst2 alleles were used as
littermate controls. Among the CG mice homozygous for Tpst2
grt
(CG-Tpst2
grt), mice with the 129-derived Lrch allele showed partial
recovery from growth retardation in both sexes, compared to mice
without the 129-derived Lrch allele. The Lrch allele showed no
obvious influence on growth in littermate controls (data not
shown). In addition, thyroid index of CG-Tpst2
grt with the 129-
derived Lrch allele showed a significant elevation compared to CG-
Tpst2
grt without the 129-derived Lrch allele for both sexes (Fig. 4C).
Thus, the congenic analysis confirmed the significant impact of
Lrch, located between D2Mit43 and D2Mit286, on TD-associated
growth retardation.
Figure 1. Plots of the individual body weights of DW-Tpst2
grt,
BC-Tpst2
grt and 129-Tpst2
grt mice at 8 weeks of age. Individual
numbers are given in parentheses. Mean value and the standard
deviation (s.d.) are indicated by horizontal and vertical lines, respec-
tively.
doi:10.1371/journal.pone.0031035.g001
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In a previous study, we demonstrated that growth retardation
by Tpst2
grt-related CH is influenced by genetic background. Mice
harboring homozygotic Tpst2
grt in a B6 genetic background, as
well as DW-Tpst2
grt, show susceptibility to CH. In contrast, the
thyroid function in 129-Tpst2
grt mice is fully recovered irrespective
of TPST2 deficiency, and the 129 strain is remarkably resistant to
growth retardation by CH [17]. Most gene targeting is carried out
in cultured ES cells derived from the 129 strain because of its
higher efficiency of germline transmission. Our data indicated that
thyroid-related gene knockout mice might sometimes appear
phenotypically normal in a 129 genetic background.
In this study, to identify the resistant gene(s) for CH, we
performed QTL analysis using backcross progenies from suscep-
tible DW and resistant 129 strain mice. Although the mapping
resolution is not good enough to distinguish two QTLs close to
each other, QTL analysis using the first principal component
Figure 2. Linkage maps displaying the QTL using the first principal component as an indicator for CH. A) Genome-wide linkage maps.
B) Details of highly significant linkages on Chr 2. Suggestive, significant and highly significant values are 6.9, 13.7 and 21.8 for male, 7.0, 14.1 and 23.0
for female, respectively. The maximum LRS score on Chr 2 is 28.9 for male and 27.0 for female, respectively. Horizontal black bars in Fig. 2B indicate
95% confidence intervals.
doi:10.1371/journal.pone.0031035.g002
Table 1. Characteristics of QTLs for growth retardation.
Sex Marker LRS % P Homozygous Heterozygous
Male D2mit255 25.5 63 ,10
25 16.2062.92 23.4462.60*
D4mit152 8.4 28 0.0037 17.6463.96 22.1364.21*
D18mit110 8.5 29 0.0036 16.8064.98 21.0263.85*
Female D2mit255 27.0 69 ,10
25 15.7361.95 20.7061.97*
The microsatellite markers linked to the indicator for CH with the highest LRS value on each Chr, percentage of the variance, genome-wide P value detected by marker
regression analysis based on 10000 permutation replicates and body weights of each genotype at 10 weeks age are indicated. %: percentage of the variance. P:
genome-wide P value as calculated by QTX software. Means 6 s.d. are shown.
*: P,0.01.
doi:10.1371/journal.pone.0031035.t001
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significant QTL on Chr 2 adjacent to D2Mit255, and suggestive
QTLs on Chrs 4 and 18 (Fig. 2). In fact, 129-derived alleles of each
QTL increased resistance to dwarfism in both BC-Tpst2
grt and
CG-Tpst2
grt mice (Table 1 and Fig. 4B). Although body weight is a
compound trait reflecting the weights of lean muscle and bones as
well as fat mass, a significant correlation between the severity of
growth delay and the degree of thyroid hypoplasia suggested the
involvement of thyroid dysplasia to growth retardation in BC-
Tpst2
grt mice (Fig. 3A and B). Indeed, a significant elevation in
thyroid index for both sexes was observed in CG-Tpst2
grt with the
129-derived Lrch allele, compared to CG-Tpst2
grt without the 129-
derived Lrch allele (Fig. 4C). This result confirmed the significant
impact of Lrch, located between D2Mit43 and D2Mit286, on TD-
associated growth retardation. Since there were complete recovery
effects on dwarfism and thyroid development in backcross
population (Fig. 1A and 3B), and the resistant gene(s) to CH in
129 strain is supposed to follow dominant inheritance, we used
backcross population for examination of growth and thyroid
development in CG mice. The partial recovery from growth
retardation in CG-Tpst2
grt mice with the 129-derived Lrch (Fig. 4B;
compared to littermate controls) suggests the effects of other
QTLs, though dosage effects of the Lrch cannot be excluded.
Further examination using intercross population will prove this
problem.
Besides the major QTL on Chr 2, we detected male specific
QTLs on Chrs 4 and 18. This may explain the sex bias for TD in
human. In fact, gender bias in TD is reported in humans, with a
female: male ratio of 1.4 for entire TD, 1.9 for ectopic thyroid
glands and 0.9 for athyreosis [5], although the reason for this
remains unclear. It is possible that the TD resistant genes are
influenced by the male sex hormone. Alternatively, QTLs detected
in this study might be correlated with genes differentially expressed
in a gender-specific manner.
By use of CH mice with TD caused by a double-heterozygous
null mutation in genes encoding Ttf1 and Pax8 (DHTP),
Amendola et al. also found that the B6 strain has a greater
susceptibility to CH in comparison to 129 strain mice [10]. They
mapped modifier genes for CH on Chrs 2 and 5 by genetic linkage
analysis, and further localized the CH-related QTL on Chr 2
(HTRC2) from 112–121 Mb [21]. In the present study, we
localized the major modifier QTL on Chr 2 from 117.9–
Figure 3. The severity of growth retardation in BC-Tpst2
grt mice is related to thyroid hypoplasia. A) Representative cross-sections of
thyroid glands of BC-Tpst2
grt mice at 10 weeks of age. Upper: a male BC-Tpst2
grt mouse with severe growth retardation (body weight was 35.2% that
of the littermate control; thyroid index=16.3%). Lower: a male BC-Tpst2
grt mouse with mild growth retardation (body weight was 81.4% that of the
littermate control; thyroid index=47.4%). B) Plots of body weight and thyroid index of BC-Tpst2
grt at 10 weeks of age. Open triangles: BC-Tpst2
grt
homozygous for D2Mit255 (n=8 and 6 for male and female, respectively), solid triangles: BC-Tpst2
grt heterozygous for D2Mit255 (n=6 and 6 for male
and female, respectively), blue triangles: the average of DW-Tpst2
grt (n=4 and 3 for male and female, respectively), red triangles: the average of 129-
Tpst2
grt (n=3 and 4 for male and female, respectively). C) Comparison of thyroid indices between genotypes at D2Mit255 in BC-Tpst2
grt mice. a:
homozygous, b: heterozygous for D2Mit255, respectively. Individual numbers are given in parentheses. Vertical lines indicate s.d. N.S.: not significant.
doi:10.1371/journal.pone.0031035.g003
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between 104.0–154.3 Mb by congenic strain analysis. This locus
overlaps HTRC2. From a subsequent transcriptional assay and
sequencing of candidate genes, they concluded that the amino acid
substitution of highly conserved tyrosine 273 to phenylalanine in
Dnajc17 (119.0 Mb), encoding for a member of the type III heat-
shock protein-40 family, results in reduced thyroglobulin (Tg)
transcription, leading to CH in B6 mice [21]. We also found a
Y273F polymorphism in Dnajc17 in DW strain mice, which is the
same as the susceptible B6 mice in the above study. However, we
could not detect any deficiency in Tg transcription, synthesis,
transportation or secretion in DW-Tpst2
grt mice [12,22]. As the
pathology of CH differs between each model, modifier genes for
Tpst2
grt-induced CH may differ from those for DHTP-induced
CH. The fact that the peak LRS on Chr 2 is between D2Mit255
and D2Mit304 (123.2–128.2 Mb), rather than between D2Mit62
and D2Mit255 (117.9–123.2 Mb) in male (Fig. 2) supports the
above idea.
Since the Tpst2
grt mutation causes TSH hyporesponsiveness
[12], we predict that the resistant factor(s) for CH in the 129 strain
are mainly involved in signal transduction downstream of TSHR
or TSH-independent activity in thyrocyte proliferation and
thyroid hormone biosynthesis. The positional MEDLINE
(http://omicspace.riken.jp/PosMed/) revealed that there are at
least 18 genes related to thyroid development and function
between D2Mit62 and D2Mit304 (Table 2). In particular, dual
oxidase 2 (Duox2) (122.1 Mb), dual oxidase maturation factor 2
(Duoxa2) (122.1 Mb) and Kv channel interacting protein 3 (Kcnip3,
also known as Dream) (127.3 Mb) agree with our prediction. Duox2
and Duoxa2 attracted our interest in that these genes are involved
in several forms of CH in human and mice [23,24]. DUOX2 is
one of the NADPH oxidases producing H2O2, which is required
for iodination of TG whose modification is prerequisite for thyroid
hormone synthesis. In addition to its transcription, enzymatic
activity of DUOX2 is also regulated by TSH signaling in human
[25,26]. DUOXA2 is essential for DUOX2 maturation and
trafficking from the endoplasmic reticulum to the plasma
membrane where DUOX2 functions [25,27]. KCNIP3 is
preferentially expressed in the central nervous system and thyroid
gland in mice, and binds to the downstream regulatory element
where its binding to the sequence suppresses the transcription of
target genes [28]. Recently, transcriptional regulation of thyroid
Figure 4. Evaluation of the effect of Lrch on TD-associated growth retardation by congenic strain analysis. A) Schematic diagram of the
genomic structure surrounding Lrch in CG mice. Gray bars indicate the minimum genomic regions derived from DW. A black bar indicates a genomic
region into which 129-derived alleles were introduced. Dotted bars represent recombined regions between the DW and 129 genomes. The numbers
to the left of the bars represent physical locations based on the MGI. B) Growth curves of CG mice. a: littermate controls, b: CG-Tpst2
grt mice
heterozygous for the 129-derived Lrch allele, c: CG-Tpst2
grt mice without the 129-derived Lrch allele. Individual numbers of a, b, c are 5, 4 and 5 for
males, and 9, 5 and 2 for females, respectively. Vertical lines indicate s.d. P,0.05: *; b versus c, {; b versus a, {; c versus a. C) Thyroid indices of CG-
Tpst2
grt. Individual numbers are given in parentheses.
doi:10.1371/journal.pone.0031035.g004
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reported [29,30]. Furthermore, constitutively active mutant
KCNIP3 interferes with thyroid cell proliferation in vitro [30]
and induces thyroid enlargement and nodular development in
mice [31]. Moreover, the regulation of TSHR activity by KCNIP3
is suggested in thyrocytes [31]. We examined the expression of
these possible candidate genes (Dnajc17, Duox2, Duoxa2 and Kcnip3)
in thyroid glands of DW and 129 strain mice with semi-
quantitative RT-PCR. However, there was no quantitative
difference observed (data not shown). To determine the resistant
genes, the generation and analysis of subcongenic mice together
with further genetic study is required.
In conclusion, genome-wide analysis and a congenic mouse
study identified a major modifier gene for Tpst2
grt-induced CH on
Chr 2, between 104.0–154.3 Mb and adjacent to D2Mit255. The
major QTL identified in our study overlaps with HTRC2 which
was identified in another study. It is intriguing that genetic linkage
analyses using distinct CH models with different origins mapped
the major QTL on the same region on Chr 2. Identification of
genes(s) responsible for resistance to hypothyroidism in 129-Tpst2
grt
mice will provide insights into the molecular events involved in
thyroid development. Moreover, the discovery of novel causative
gene(s) should lead to the development of treatment strategies for
thyroid cell disorders including thyroid tumors and hyperthyroid-
ism, as well as hypothyroidism.
Supporting Information
Figure S1 Details of male-specific suggestive linkages
on Chr 4 and Chr 18. Suggestive, significant and highly
significant values are 6.9, 13.7 and 21.8, respectively. Horizontal
black bars represent 95% confidence intervals. The maximum
LRS is 8.4 for Chr 4, and 10.6 for Chr 18.
(TIF)
Figure S2 Plots of body weight and thyroid index of BC-
WT mice at 10 weeks of age. Solid triangles: BC-WT (n=15
and 10 for male and female, respectively), blue triangles: the
average of the DW mice with wild-type Tpst2
grt allele (n=5 and 3
for male and female, respectively), red triangles: the average of the
129 mice with wild-type Tpst2
grt allele (n=5 and 3 for male and
female, respectively).
(TIF)
Table S1 List of microsatellite markers used for the QTL
analysis.
(XLSX)
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